← FDA DRUG APPROVALS

FDA ANDA · ANDA077458

RANITIDINE HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
ANDA077458
TYPE
ANDA
ORIGINAL APPROVAL
2006-02-16
LATEST ACTION
2010-01-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

RANITIDINE HYDROCHLORIDEDiscontinued
RANITIDINE HYDROCHLORIDE EQ 25MG BASE/ML · INJECTABLE · INJECTION

Approval history

2010-01-29Labeling · Supplement 2AP
2009-06-18Labeling · Supplement 1AP
2006-02-16OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →